论文部分内容阅读
目的:探讨舒血宁治疗急性脑缺血的临床效果。方法:收治急性脑缺血患者128例,随机平分成两组,对照组给予依达拉奉静脉滴注,观察组在此基础上给予舒血宁注射液静脉滴注。结果:治疗14 d神经功能缺损评分观察组明显低于对照组。观察组治疗后血脂指标、血液流变学明显优于对照组,差异有统计学意义(P<0.05);观察组基本治愈率、进步率和总有效率均优于对照组,差异有统计学意义(P<0.05)。结论:舒血宁治疗急性脑缺血恢复快,疗效好。
Objective: To investigate the clinical effect of Shu Xue Ning on acute cerebral ischemia. Methods: A total of 128 patients with acute cerebral ischemia were randomly divided into two groups. The control group was treated with edaravone. The observation group received Shuxuening injection by intravenous drip. Results: The score of neurological deficit in the 14-day treatment group was significantly lower than that of the control group. Observed group after treatment, blood lipid indicators, hemorheology was significantly better than the control group, the difference was statistically significant (P <0.05); observation group, the basic cure rate, progress rate and total effective rate were better than the control group, the difference was statistically significant Significance (P <0.05). Conclusion: Shuxuening treatment of acute cerebral ischemia recovery faster, good effect.